Search

Your search keyword '"Au, Lewis"' showing total 161 results

Search Constraints

Start Over You searched for: Author "Au, Lewis" Remove constraint Author: "Au, Lewis"
161 results on '"Au, Lewis"'

Search Results

1. Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology

2. Biomarkers of therapy response and resistance in clear cell renal cell carcinoma ; and, Adaptive immune response to SARS-CoV-2 and COVID-19 vaccines in cancer patients

3. SABR for oligometastatic renal cell carcinoma

4. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

5. Pervasive chromosomal instability and karyotype order in tumour evolution

6. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study

7. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

8. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

9. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2

12. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

14. Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

15. Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

16. Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

17. Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

18. Abstract A011: Detection of disseminated tumor cells in advanced clear cell renal cell carcinoma through research autopsy

19. Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways

20. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

22. Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

23. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study

25. Abstract PR002: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

26. Abstract A012: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

27. Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

28. Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay

29. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

30. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

31. Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

32. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

33. Immune responses following third COVID-19 vaccination are reduced in patients with hematologic malignancies compared to patients with solid cancer

34. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

35. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study

36. Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

37. Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

38. Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis

39. Cytokine release syndrome in a patient with colorectal cancer following vaccination with BNT162b2 (tozinameran)

40. Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma

41. Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study

42. Spatial patterns of tumour growth impact clonal diversification: computational modelling and evidence in the TRACERx Renal study

43. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

44. Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study

46. Abstract PO-091: CAPTURE: Cancer and COVID-19 antiviral immune monitoring study

47. Selection of metastasis competent subclones in the tumour interior: TRACERx renal

48. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

49. Selection of metastasis competent subclones in the tumour interior.

50. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Catalog

Books, media, physical & digital resources